| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/29/1997 | US5652271 Therapeutic agents |
| 07/29/1997 | US5652266 Skin improvement, a-hydroxy acid, salicylic acid or ester, and retinoid |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652235 Method of using spiro piperidines to promote the release of growth hormone |
| 07/29/1997 | US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 07/29/1997 | US5652221 Method of treating defective glucose metabolism using synthetic insulin substances |
| 07/29/1997 | US5652216 Pharmaceutical preparation |
| 07/29/1997 | US5652124 α-glycosyl hesperidin, and its preparation and uses |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026237A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | WO1997026013A1 Obesity protein formulations |
| 07/24/1997 | WO1997026012A1 Obesity protein formulations |
| 07/24/1997 | WO1997026011A1 Obesity protein formulations |
| 07/24/1997 | WO1997026004A1 Obesity protein formulations |
| 07/24/1997 | WO1997025998A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997021993A3 Nuclear receptor ligands and ligand binding domains |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2243505A1 Obesity protein formulations |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2243295A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | CA2216600A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 07/23/1997 | EP0785214A2 Amylase inhibitors |
| 07/23/1997 | EP0784982A2 Obesity protein formulations |
| 07/23/1997 | EP0784981A2 Obesity protein formulations |
| 07/23/1997 | EP0784979A2 Obesity protein formulations |
| 07/23/1997 | EP0784978A2 Agents for inhibiting accumulation of visceral fat |
| 07/23/1997 | EP0784681A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 07/23/1997 | EP0784624A1 Purine and guanine compounds as inhibitors of pnp |
| 07/23/1997 | EP0784612A1 Urea derivatives and their use as acat-inhibitors |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0581797B1 Novel thiophene-2-carboxylic acid derivatives and process for their production |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/23/1997 | CN1155287A Cross-linked polymers for removing bile salts from patient |
| 07/23/1997 | CN1154857A Hypoglycemic instant powder and prepn. method |
| 07/22/1997 | US5650523 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one |
| 07/22/1997 | US5650492 P-40 homodimer of interleukin-12 |
| 07/22/1997 | US5650486 Monomeric insulin analog formulations |
| 07/22/1997 | US5650168 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 07/22/1997 | US5650157 Pharmaceutical compositions and methods |
| 07/19/1997 | CA2195051A1 Amylase inhibitors |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025424A1 Ob protein receptor and related compositions and methods |
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 07/17/1997 | WO1997025311A1 Novel tricyclic compounds and drug compositions containing the same |
| 07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025043A1 A method of treating hypercholesterolemia and related disorders |
| 07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783524A1 Peptides and pharmaceutical compositions comprising them |
| 07/16/1997 | EP0783514A1 Sterol compositions from pulping soap |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 07/16/1997 | EP0783315A1 Hydration compositions for human or animal bodies |
| 07/16/1997 | EP0717751B1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
| 07/16/1997 | CN1154255A Capsulized traditional Chinese proprietary medicine- |
| 07/15/1997 | US5648387 Carboxyalkylethers, formulations, and treatment of vascular diseases |
| 07/15/1997 | US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 07/15/1997 | US5648382 Angiogenesis inhibitor |
| 07/15/1997 | US5648076 Administering antigrowth factor antibodies following surgery |
| 07/15/1997 | US5647974 Hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 07/10/1997 | WO1997024440A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/10/1997 | WO1997024333A1 Preventives/remedies for complications of diabetes |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |
| 07/09/1997 | EP0782986A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/09/1997 | EP0782581A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 07/09/1997 | EP0720608B1 Novel dihispidine derivatives, process for producing them and medicaments containing these compounds |
| 07/09/1997 | EP0478775B1 Peptide derivatives |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/08/1997 | US5646272 Bile acid conjugates of proline hydroxylase inhibitors |
| 07/08/1997 | US5646170 Tetrazole alkyl amide acat inhibitors |
| 07/08/1997 | US5646168 Hypoglycemic hydroxyurea derivatives |
| 07/08/1997 | US5646152 Treating psychological disorders with corticotropin releasing factor antagonists |
| 07/08/1997 | US5646149 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | US5646140 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 07/08/1997 | US5646118 Glutamine, fatty acid, insulin-like growth factors |
| 07/08/1997 | US5646116 Administering insulin-like growth factor i to a mammal |
| 07/08/1997 | US5646113 Treatment of partial growth hormone insensitivity syndrome |
| 07/08/1997 | US5646035 Method for preparing an expanded culture and clonal strains of pancreatic, thyroid or parathyroid cells |
| 07/08/1997 | CA2127878C Fo-1289 substance and its production |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |